The importance of central airway dilatation in patients with bronchiolitis obliterans

Aguilar PR, Michelson AP, Isakow W. Obliterative bronchiolitis. Transplantation 2016; 100: 272–283.

Barker AF, Bergeron A, Rom WN, et al. Obliterative bronchiolitis. N Engl J Med 2014; 370: 1820–1828.

Chen-Yoshikawa TF, Sugimoto S, Shiraishi T, et al. Prognostic factors in lung transplantation after

hematopoietic stem cell transplantation. Transplantation 2018; 102: 154–161.

Verleden SE, Sacreas A, Vos R, et al. Advances in understanding bronchiolitis obliterans after lung

transplantation. Chest 2016; 150: 219–225.

de Jong PA, Dodd JD, Coxson HO, et al. Bronchiolitis obliterans following lung transplantation: early

detection using computed tomographic scanning. Thorax 2006; 61: 799–804.

Belloli EA, Degtiar I, Wang X, et al. Parametric response mapping as an imaging biomarker in lung transplant

recipients. Am J Respir Crit Care Med 2017; 195: 942–952.

Cheng GS, Selwa KE, Hatt C, et al. Multicenter evaluation of parametric response mapping as an indicator of

bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Am J Transplant 2020; 20:

2198–2205.

Gunn ML, Godwin JD, Kanne JP, et al. High-resolution CT findings of bronchiolitis obliterans syndrome after

hematopoietic stem cell transplantation. J Thorac Imaging 2008; 23: 244–250.

Song I, Yi CA, Han J, et al. CT findings of late-onset noninfectious pulmonary complications in patients with

pathologically proven graft-versus-host disease after allogeneic stem cell transplant. AJR Am J Roentgenol

2012; 199: 581–587.

https://doi.org/10.1183/23120541.00123-2021

ERJ OPEN RESEARCH

ORIGINAL RESEARCH ARTICLE | M. KOGO ET AL.

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

Galban CJ, Boes JL, Bule M, et al. Parametric response mapping as an indicator of bronchiolitis obliterans

syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014; 20: 1592–1598.

Leung AN, Fisher K, Valentine V, et al. Bronchiolitis obliterans after lung transplantation: detection using

expiratory HRCT. Chest 1998; 113: 365–370.

Ooi GC, Peh WC, Ip M. High-resolution computed tomography of bronchiolitis obliterans syndrome after bone

marrow transplantation. Respiration 1998; 65: 187–191.

Lentz D, Bergin CJ, Berry GJ, et al. Diagnosis of bronchiolitis obliterans in heart-lung transplantation

patients: importance of bronchial dilatation on CT. AJR Am J Roentgenol 1992; 159: 463–467.

Sargent MA, Cairns RA, Murdoch MJ, et al. Obstructive lung disease in children after allogeneic bone marrow

transplantation: evaluation with high-resolution CT. AJR Am J Roentgenol 1995; 164: 693–696.

Gazourian L, Coronata AM, Rogers AJ, et al. Airway dilation in bronchiolitis obliterans after allogeneic

hematopoietic stem cell transplantation. Respir Med 2013; 107: 276–283.

Gazourian L, Ash S, Meserve EEK, et al. Quantitative computed tomography assessment of bronchiolitis

obliterans syndrome after lung transplantation. Clin Transplant 2017; 31: 12943.

Bedi P, Chalmers JD, Goeminne PC, et al. The BRICS (Bronchiectasis Radiologically Indexed CT Score): a

multicenter study score for use in idiopathic and postinfective bronchiectasis. Chest 2018; 153: 1177–1186.

Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and

validation study. Am J Respir Crit Care Med 2014; 189: 576–585.

Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6:

Suppl. 16, 5–40.

Bhatt SP, Soler X, Wang X, et al. Association between functional small airway disease and FEV1 decline in

chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2016; 194: 178–184.

Takeuchi Y, Miyagawa-Hayashino A, Chen F, et al. Pleuroparenchymal fibroelastosis, and non-specific

interstitial pneumonia: frequent pulmonary sequelae of haematopoietic stem cell transplantation.

Histopathology 2015; 66: 536–544.

Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary

disease. N Engl J Med 2004; 350: 2645–2653.

Zheng PP, van der Weiden M, Kros JM. Fast-tracking of co-localization of multiple markers by using the

Nanozoomer slide scanner and NDPViewer. J Cell Physiol 2014; 229: 967–973.

Tanabe N, Vasilescu DM, Kirby M, et al. Analysis of airway pathology in COPD using a combination of

computed tomography, micro-computed tomography, and histology. Eur Respir J 2018; 51: 1701245.

Culiner, MM. Obliterative bronchitis and bronchiolitis with bronchiectasis. Dis Chest 1963; 44: 351–360.

Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed

tomography features and pulmonary function tests. Thorax 2000; 55: 198–204.

Washko GR, Colangelo LA, Estepar RSJ, et al. Adult life-course trajectories of lung function and the

development of emphysema: The CARDIA lung study. Am J Med 2020; 133: 222–230.e211.

King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis 2009; 4: 411–419.

Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax 1952; 7: 213–239.

Richardson H, Dicker AJ, Barclay H, et al. The microbiome in bronchiectasis. Eur Respir Rev 2019; 28: 190048.

https://doi.org/10.1183/23120541.00123-2021

10

...